 |
市场调查报告书
商品编码
1146346
瞳孔计市场 - COVID-19 的增长、趋势、影响和预测（2022-2027 年）Pupillometer Market - Growth, Trends, and Forecasts (2022 - 2027) |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计瞳孔计市场在预测期间（2022-2027 年）的复合年增长率为 5.1%。
COVID-19 大流行对许多国家已经不堪重负的公共卫生系统产生了巨大影响。此外，医疗保健行业的重点已转移到流行病危机管理上。这带来了僱用、保留和保护受过技术培训并受到鼓励的卫生人力的挑战。此外，全球封锁导致医护人员短缺。此外，全球医疗器械供应链中断。此外，瞳孔计市场在 COVID-19 大流行期间也面临不利影响。疫情期间，眼科服务锐减。因此，这导致对瞳孔计的需求减少。
此外，冠状病毒可以通过眼睛的结膜进入人体。因此，眼科医生可能处于感染高风险之中。这是因为眼科医生在检查过程中离患者很近，使其更容易受到飞沫传播。因此，世界卫生组织 (WHO) 已强制采取预防措施，避免眼神接触以减少传播。因此，世界各地的许多眼科医生都暂时停止了执业，并发出警告。在一个国家，为眼科实践制定了特殊指南，并暂停了实践。例如，印度政府卫生和家庭福利部于 2020 年 12 月发布了 COVID-19 情景下的安全眼保健指南。该指南旨在最大程度地减少 COVID-19 在眼科医护人员中的传播。因此，收容区内的眼保健设施仍然关闭。因此，这些因素在 COVID-19 大流行期间影响了监控市场，2020 年对瞳孔计的需求下降。然而，从 2021 年开始，市场逐渐从跌势中復苏。这是因为医疗器械供应链服务已经恢復。
导致调查市场增长的主要因素包括提高与手动瞳孔成像相关的瞳孔计的意识以及技术进步。促进市场增长的其他因素包括需要使用瞳孔计的疾病流行率激增。
多年来，手动瞳孔成像一直是获取患者瞳孔信息的主要方法。在这种传统方法中，使用手电筒或手电筒手动评估瞳孔反应性，并使用瞳孔规来估计瞳孔大小。但是，手动瞳孔评估可能不准确且不一致。此外，可能会出现评价人之间的差异。因此，瞳孔计优于手动评估。这是因为这些光学器件在技术上具有优势。例如，较新的瞳孔计包括红外摄像机、LED 光源、条形码扫描仪、支持蓝牙的数据传输和其他高级功能。此外，条形码扫描仪等功能消除了对外部扫描仪的需求。条形码扫描仪等功能还消除了对外部扫描仪的需求，并避免了手动输入患者 ID 时的转录错误。此外，市场上的新型非侵入性手持式光学扫描仪可以可靠、客观地测量瞳孔大小、对称性和反应性。例如，NeuroOptics 的 NPi-300 瞳孔计系统可以对瞳孔反应进行数值量化，神经瞳孔指数 (NPi) 允许对瞳孔反应进行严格的解释和分类。它还提供有关瞳孔对光反射是否在正常或异常范围内的信息。此外，您还可以查看光反射是否在非典型、不可测量或无响应范围内。这些好处使其成为医生的最爱。
它是视神经、脑肿瘤、视网膜、脑血管疾病和弱视中发生的不对称的指标。当疾病或障碍以不对称方式表现时尤其如此。因此，脑肿瘤等疾病患病率的激增导致对用于检测脑肿瘤患者 APD 的瞳孔计的需求增加。例如，美国临床肿瘤学会 (ASCO) 估计，到 2022 年，美国估计将有 25,050 名成年人被诊断出患有脑和脊髓原发性癌症肿瘤。
此外，神经瞳孔指数 (NPi) 测试也是必不可少的，尤其是对于患有中风、动脉瘤和心臟骤停等疾病的患者。因此，心臟骤停患病率的上升也导致对瞳孔计的需求激增，从而推动了研究市场的增长。例如，美国心臟协会发布并更新了其 2022 年的“心臟和中风统计”报告。根据该报告，美国每年发生超过 356,000 例院外心臟骤停 (OHCA)。
因此，由于上述因素，所研究的市场预计将在分析期内增长。然而，瞳孔计的高成本和专业临床医生的短缺影响了它们在新兴国家的应用。这反过来又会影响瞳孔计市场的增长。
主要市场趋势
预计视频瞳孔计将在预测期内强劲增长
与数字瞳孔计相比，视频瞳孔计更先进。例如，这些设备可以捕获整个瞳孔活动。此外，视频瞳孔计，例如 Konan Medical USA Inc. 的 EyeKinetix 瞳孔计，利用红外条件下的高分辨率摄像机记录双侧瞳孔对单眼视觉刺激的反应。此外，EyeKinetix 可以同时记录直接和同意瞳孔对光反射。此外，近年来视频瞳孔计的获批也是需求激增的原因之一。例如，NeuroOptics Inc. 于 2021 年 7 月在美国推出了 NPi-300 瞳孔计。此外，NPi-300 瞳孔计配备了先进的功能，例如 LED 光源、高精度红外摄像头和广泛的微处理器功能。因此，这些功能导致市场需求激增，并推动了市场的增长。
此外，与数字瞳孔计相比，NPi-300 等视频瞳孔计是自动且快速的。这消除了其他检查方法可能发生的人为错误。因此，这导致对视频瞳孔计的需求激增，从而推动市场增长。因此，这些设备已成为临床医生的首选。
预计北美将主导瞳孔计市场
由于该地区有众多提供瞳孔计的主要参与者，预计北美将主导市场。例如，在北美运营的主要参与者包括 Essilor Group (Essilor Instruments)、US Ophthalmic.、NeurOptics Inc、Konan Medical USA Inc 和 Reichert Inc.。
此外，准确的神经系统评估和瞳孔评估对于检测创伤性脑损伤 (TBI) 患者的神经系统恶化非常重要。因此，该地区脑外伤病例激增是推动市场增长的另一个因素。此外，瞳孔计用于检查患有视网膜疾病（例如黄斑变性、糖尿病性视网膜病变和眼内肿瘤）的患者的瞳孔反应。此外，老年人群更容易出现黄斑变性等视网膜疾病。此外，根据 BrightFocus 基金会的数据，50 至 59 岁的人患老年性黄斑变性的风险为 2%。对于 75 岁及以上的人来说，这一比例接近 30%。例如，根据2021年发布的《美国健康排名高级报告》，美国约有16.5%的人口年龄在65岁及以上。此外，预测估计预计到 2050 年，美国 65 岁及以上的总人口将增加到 8570 万。同样，加拿大人口老龄化加剧也是推动北美市场增长的一个因素。例如，根据加拿大政府机构加拿大统计局的数据，到 2021 年 7 月，加拿大将有 7,081,792 名 65 岁及以上的人。此外，根据人口预测，到 2025 年，老年人口可能占人口的五分之一以上，到 2059 年将达到四分之一。因此，在美国和加拿大，越来越多的老年人患有视网膜疾病，这推动了对瞳孔计的需求增加，并推动了北美市场的增长。
因此，由于上述因素，预计北美地区的研究市场将增长。
竞争格局
由于有多家公司在全球和地区开展业务，因此瞳孔仪市场竞争激烈。在市场上运营的主要公司有NeurOptics Inc.、Essilor Group（Essilor Instruments）、Visionix、US Ophthalmic.、NIDEK SA、HAAG-STREIT GROUP、Reichert Inc、Konan Medical USA Inc、Good-Lite Company、Grobet USA（Vigor Optical）。
其他特典
- Excel 格式的市场预测 (ME) 表
- 三个月的分析师支持
内容
第 1 章介绍
- 研究假设和市场定义
- 调查范围
第 2 章研究方法
第 3 章执行摘要
第 4 章市场动态
- 市场概览
- 市场促进因素
- 由于技术进步，提高了对瞳孔计的认识
- 需要使用瞳孔计的疾病患病率激增
- 市场抑制因素
- 瞳孔计成本高，专家短缺
- 波特五力分析
- 新进入者的威胁
- 买方/消费者议价能力
- 供应商的议价能力
- 替代品的威胁
- 竞争公司之间的敌对关係
第 5 章市场细分（基于价值的市场规模：100 万美元）
- 按形式
- 手持式瞳孔计
- 台式瞳孔计
- 按类型
- 数位高温计
- 视频瞳孔计
- 按应用
- 眼科
- 神经内科
- 其他用途
- 按最终用户
- 医院
- 眼科诊所
- 其他最终用户
- 按地区
- 北美
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 德国
- 英国
- 法国
- 意大利
- 西班牙
- 其他欧洲地区
- 亚太地区
- 中国
- 日本
- 印度
- 澳大利亚
- 韩国
- 其他亚太地区
- 世界其他地区
- 北美
第 6 章竞争格局
- 公司简介
- NeurOptics Inc.
- Essilor Instruments USA
- Visionix
- US Ophthalmic.
- NIDEK SA
- HAAG-STREIT GROUP
- Reichert Inc.
- Konan Medical USA Inc.
- Good-Lite Company
- Grobet USA.（Vigor Optical）
第 7 章市场机会和未来趋势
The pupillometer market is expected to register a CAGR of 5.1% over the forecast period (2022-2027).
The COVID-19 pandemic drastically affected the already overburdened public health systems in many countries. Additionally, the core focus of the healthcare industry shifted to pandemic crisis management. This led to challenges faced in hiring, retaining, and protecting technically trained, and encouraged health professionals. Moreover, the worldwide lockdowns led to a shortage of healthcare staff. Furthermore, the supply chain of medical devices around the world was also obstructed. In addition, the pupillometer market also faced detrimental impacts during the COVID-19 pandemic. There was a sharp decline in ophthalmology services during the pandemic. Hence, this leads to a decrease in demand for pupillometers.
Furthermore, coronavirus can enter the body through the eye's conjunctiva. Hence, ophthalmologists might be at high risk of getting infected. This is because of the proximity to patients during the examination, predisposing ophthalmologists to droplet transmission. Thus, the world health organization (WHO) commissioned precautionary measures to avoid contact with the eyes to reduce transmission. Therefore, as a cautionary measure, many ophthalmologists across the world suspended their practices temporarily. In certain countries, special guidelines were laid for ophthalmology practices, and services were suspended. For instance, the Government of India Ministry of Health and Family Welfare issued guidelines on safe ophthalmology practices in the COVID-19 scenario in December 2020. These guidelines were aimed at minimizing the spread of COVID-19 among the ophthalmic healthcare staff. Hence, the Eye care facilities in containment zones remained closed. Thus, these factors led to a decline in the demand for pupillometers in the year 2020 thereby affecting the studied market during the COVID-19 pandemic. However, the market is gradually recovering from the decline since the year 2021. This is because the medical device supply chain services resumed.
The major factor leading to the growth of the studied market includes the rise in awareness associated with pupillometers over manual pupillary examination coupled with technological advancements. Other factors that contribute to the growth of the market include, the surge in the prevalence of disorders requiring the use of pupillometer.
Over the years, manual pupil assessment remained a major way of obtaining pupillary information about a patient. This conventional technique involved the usage of a penlight or flashlight to manually evaluate pupil reactivity and a pupil gauge to estimate pupil size. However, manual pupillary assessment can lead to inaccuracies and inconsistencies. Furthermore, it can result in inter-examiner variability. Hence, pupillometers are preferred over manual assessment. This is because these optical devices are technically advanced. For instance, the new pupillometers have infrared cameras, an LED light source, a barcode scanner, Bluetooth-enabled data transfer, and other advanced features. In addition, features such as the barcode scanner eliminate the need for an external scanner. Hence, this avoids any transcription errors during manual entries of a patient ID. Furthermore, the novel noninvasive, handheld optical scanners available on the market can provide reliable and objective measurements of pupillary size, symmetry, and reactivity. For instance, the NPi-300 pupillometer system offered by NeurOptics, Inc. can quantify pupil reactivity on a numeric scale, and the Neurological Pupil index (NPi) allows rigorous interpretation and classification of the pupil response. The device also delivers information on whether the pupillary light reflex falls within the normal range or abnormal range. Furthermore, the device can also check if the light reflex is in, the atypical, immeasurable, or non-reactive range. Hence, these advantages make them a preferable choice among physicians.
Afferent pupillary defect (APD) is a measure of asymmetry which may occur with the optic nerve, brain tumors, retinal, or cerebral vascular disease, and amblyopia. It occurs specifically when the disease or disorder is presenting asymmetrically. Hence, the surge in prevalence of diseases such as brain tumors leads to a rise in demand for pupillometers which are used to detect APD in patients suffering from a brain tumor. For instance, according to an estimate by the American Society of Clinical Oncology (ASCO), 25,050 adults are estimated to be diagnosed with primary cancerous tumors of the brain and spinal cord in the United States in the year 2022.
In addition, neurological pupil index (NPi) testing is essential in a patient with diseases such as stroke, aneurysm, and cardiac arrest among others. Thus, the rise in prevalence of cardiac arrest also leads to a surge in demand for pupillometers thereby driving the growth of the market studied. For instance, The American Heart Association released and updated a report "Heart and Stroke Statistics" in 2022. According to the report, each year in the United States there are more than 356,000 out-of-hospital cardiac arrests (OHCA).
Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. However, the high cost of pupillometers and lack of specialized clinicians impacts the penetration in emerging countries. This in turn affects the growth of the pupillometer market.
Key Market Trends
Video Pupillometer is Expected to Witness High Growth Over the Forecast Period
Video pupillometers are more advanced compared to digital pupillometers. For instance, these devices can capture the entire pupillary activity. Moreover, video pupillometers such as The EyeKinetix pupillometer offered by Konan Medical USA Inc. utilize high-definition video cameras under infrared conditions to record the bilateral pupil responses to monocular visual stimuli. Furthermore, EyeKinetix simultaneously records both direct and consensual pupillary light reflexes. In addition, the recent approval of video pupillometers is another factor that leads to a surge in their demand. For instance, NeurOptics Inc. launched NPi-300 Pupillometer in the United States in July 2021. Furthermore, NPi-300 Pupillometer has advanced features such as, it includes a LED light source, a high-precision infra-red camera, and extensive microprocessor capability. Hence, these features lead to a surge in demand in the market thereby driving the growth of the market.
Furthermore, video pupillometer such as NPi-300 is automatic and quick in comparison to digital pupillometers. Hence, automatic pupillometers remove any human errors that could occur with other testing methods. Thus, this leads to a surge in demand for video pupillometers thereby driving the growth of the market. Hence, these advantages offered by them make these devices a preferred choice among clinicians.
North America is Expected to Dominate the Pupillometer Market
North America is expected to dominate the market due to the presence of a large number of key players offering pupillometers in the region. For instance, some of the key players operating in North America include Essilor Group (Essilor Instruments), US Ophthalmic., NeurOptics Inc., Konan Medical USA Inc., and Reichert Inc.
In addition, accurate neurological and pupillary assessment are critical for the detection of neurological deterioration in patients with traumatic brain injury (TBI). Hence, the surge in cases of traumatic brain injury in the region is another factor that drives the growth of the market. Furthermore, pupillometers are employed to check pupil response in patients with retinal diseases such as macular degeneration, diabetic retinopathy, intraocular tumors, and others. In addition, retinal diseases such as macular degeneration are more predisposed in the geriatric population. Moreover, according to BrightFocus Foundation, the risk of getting advanced age-related macular degeneration is 2% in people ages 50- 59. This risk is nearly 30% for those over the age of 75. For instance, according to America's Health Rankings Senior Report published in 2021, about 16.5% of the United States population is of age 65 years or above. In addition, according to the projected estimates, the total number of people aged 65 years or above is expected to rise to 85.7 million in the United States by the year 2050. Similarly, the rise in the geriatric population in Canada is also a factor that drives the growth of the market in North America. For instance, according to Statistics Canada, an agency of the Government of Canada, in July 2021, there were 7,081,792 seniors aged 65 and older in Canada. Furthermore, as per the demographic projections, senior citizens are expected to account for over one-fifth of the population by 2025 and could reach one-quarter by 2059. Thus, the rise in the geriatric population that suffers from retinal diseases in the United States and Canada drives the rise in demand for pupillometers thereby driving the growth of the market in North America.
Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.
Competitive Landscape
The pupillometer market is competitive due to the presence of several companies operating globally as well as regionally. The key companies operating in the market are NeurOptics Inc., Essilor Group (Essilor Instruments), Visionix, US Ophthalmic., NIDEK SA, HAAG-STREIT GROUP, Reichert Inc., Konan Medical USA Inc., Good-Lite Company, and Grobet USA (Vigor Optical).
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Rise in Awareness Associated with Pupillometers Coupled with Technological Advancements
- 4.2.2 Surge in Prevalence of Disorders Requiring the Use of Pupillometer
- 4.3 Market Restraints
- 4.3.1 High Cost of Pupillometers and Lack of Specialized Clinicians
- 4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
- 5.1 By Modality
- 5.1.1 Handheld Pupillometer
- 5.1.2 Table Top Pupillometer
- 5.2 By Type
- 5.2.1 Digital Pupillometer
- 5.2.2 Video Pupillometer
- 5.3 By Application
- 5.3.1 Ophthalmology
- 5.3.2 Neurology
- 5.3.3 Other Applications
- 5.4 By End User
- 5.4.1 Hospitals
- 5.4.2 Eye Clinics
- 5.4.3 Other End User
- 5.5 Geography
- 5.5.1 North America
- 5.5.1.1 United States
- 5.5.1.2 Canada
- 5.5.1.3 Mexico
- 5.5.2 Europe
- 5.5.2.1 Germany
- 5.5.2.2 United Kingdom
- 5.5.2.3 France
- 5.5.2.4 Italy
- 5.5.2.5 Spain
- 5.5.2.6 Rest of Europe
- 5.5.3 Asia-Pacific
- 5.5.3.1 China
- 5.5.3.2 Japan
- 5.5.3.3 India
- 5.5.3.4 Australia
- 5.5.3.5 South Korea
- 5.5.3.6 Rest of Asia-Pacific
- 5.5.4 Rest of the World
- 5.5.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 NeurOptics Inc.
- 6.1.2 Essilor Instruments USA
- 6.1.3 Visionix
- 6.1.4 US Ophthalmic.
- 6.1.5 NIDEK SA
- 6.1.6 HAAG-STREIT GROUP
- 6.1.7 Reichert Inc.
- 6.1.8 Konan Medical USA Inc.
- 6.1.9 Good-Lite Company
- 6.1.10 Grobet USA. (Vigor Optical)
